A sober look at dexamethasone

A Covid-19 blog post for the non-expert It stared with a 16th June 2020 press release  from the University of Oxford “Low-cost dexamethasone reduce death by up to one third in hospitalised patients with severe respiratory complications of COVID-19” – which triggered the equivalent of a media cytokine storm (pun explained shortly). I do not want,Continue reading “A sober look at dexamethasone”